by Jordana Choucair | Mar 22, 2022 | Opioid/Substance Use Disorders
A new RAND Corp. study found that less than a third of patients who were given drugs in emergency departments to treat opioid addiction follow up and continue their treatments. The study examined 92 percent of prescriptions filled at U.S. retail pharmacies before and...
by Jordana Choucair | Mar 22, 2022 | Opioid/Substance Use Disorders
According to a new study published in JAMA, alcohol-related deaths reached record levels during the first year of the COVID-19 pandemic. The number of deaths involving alcohol increased from 78, 927 in 2019 to 99,017 in 2020. Young adults ages 25 to 44 experienced the...
by Jordana Choucair | Mar 15, 2022 | Opioid/Substance Use Disorders
The House Oversight and Reform Committee asked the Justice and Treasury departments to review tax deductions claimed by four drug companies that agreed to a $26 billion settlement to end lawsuits tied to the opioid crisis. Lawmakers said the companies may be trying to...
by Jordana Choucair | Mar 14, 2022 | Opioid/Substance Use Disorders
Black Americans fatally overdosed in 2020 at a higher rate than white Americans for the first time since 1999. The rise of fentanyl, which is more deadly than heroin or prescription opioids, is driving the overdose rate higher and changing its demographics. The...
by Jordana Choucair | Mar 11, 2022 | Opioid/Substance Use Disorders
The HHS Office of the Inspector General (OIG) authored a new advisory legal opinion that clears the way for Boston-based DynamiCare Health to use of contingency management – a harm reduction technique that pays people addicted to drugs to remain clean. Under the...
by Jordana Choucair | Mar 10, 2022 | Opioid/Substance Use Disorders
A judge approved a new $6 billion settlement between the Sackler family and dozens of local governments that accused Purdue Pharma of fueling the opioid crisis, overruling objections from the Department of Justice and 20 states. The deal, which replaces an earlier...
Recent Comments